Postmarketing non-interventional safety study on medicinal products containing aromatase inhibitors, Anastrozol Actavis 1 mg, Exemestan Actavis 25 mg, Trozara 2,5 mg First published 02/11/2015 Last updated 02/11/2015 EU PAS number:EUPAS11481 Study Planned